China Money Network
Login
Join

Matrix China Leads $14M Round In Precision Medicine Start-Up TopGene

  • December 21, 2016 — 19:24 CST

This Data Is Locked!

This area is available only to Subscribers.

Matrix Partners China has led a series A funding round worth over RMB100 million (US$14 million) in TopGene, a Guangzhou-based DNA testing and precision medicine... [DATA LOCKED]

UNLOCK DATA

Follow the Money & Subscribe for Access to the Best Data and Intelligence on Chinese Venture Capital Deals

Join

Access Thousands of Data Points to Monitor Chinese Private Equity Deal Movement and Relationships

Already Have an Account?

Login
Related Topics:

Related Data: